Syndax Stock Falls After Axatilimab IPF Trial Failure Syndax Pharmaceuticals Stock Falls 15% After Axatilimab Fails IPF Trial Syndax Pharmaceuticals shares fell sharply in after-hours trading ... October 13, 2026 Read Guide →
